Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica
- 1 December 2007
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 101 (12) , 1219-1222
- https://doi.org/10.1016/j.trstmh.2007.07.012
Abstract
Summary. Triclabendazole is the drug of choice against Fasciola hepatica infections in humans and animals. However, parasite resistance against triclabendazoleKeywords
This publication has 18 references indexed in Scilit:
- The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepaticaJournal of Antimicrobial Chemotherapy, 2006
- Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepaticaParasitology, 2006
- Artesunate and artemether are effective fasciolicides in the rat model and in vitroJournal of Antimicrobial Chemotherapy, 2006
- Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and MalariaPLoS Medicine, 2006
- Triclabendazole for the treatment of fascioliasis and paragonimiasisExpert Opinion on Investigational Drugs, 2005
- Emerging Foodborne TrematodiasisEmerging Infectious Diseases, 2005
- Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitroZeitschrift Fur Parasitenkunde-Parasitology Research, 2004
- Efficacy of an experimental fasciolicide against immature and mature Fasciola hepatica in artificially infected calvesZeitschrift Fur Parasitenkunde-Parasitology Research, 2003
- Artemisinins target the SERCA of Plasmodium falciparumNature, 2003
- Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheepPublished by Wiley ,1984